Diseases that require pediatric gastrointestinal endoscopy
Conditions
Interventions
The fospropofol disodium group (Group F):After the child was admitted to the room and given routine monitoring, a single dose of 10 µg/kg of alfentanil was slowly injected intravenously under nasal ca
Propofol Group (Group P):After the child was admitted to the room and given routine monitoring, a single dose of 10 µg/kg of alfentanil was slowly injected intravenously under nasal cannula oxygen sup
Sponsors
Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine
Eligibility
Sex/Gender
All
Age
3 Years to 17 Years
Inclusion criteria
Inclusion criteria: 1.Age 3–17 years; 2.No gender restrictions; 3.ASA class I–II; 4.Undergoing digestive endoscopy under non-intubated general anesthesia; 5.Family members have signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1.Known or suspected allergy to propofol or any drug specified in this trial; 2. Requiring special care or supervision from a court or social welfare institution; 3. Received general anesthesia within 14 days prior to the experiment; 4. Participated in clinical trials of other drugs within 3 months before screening; 5. Comorbidity with other serious diseases, including severe cardiovascular disease, severe anemia, liver or kidney dysfunction, neurological disorders (including cognitive impairment or epilepsy), or acute angle-closure glaucoma; 6. Presence of relatively serious respiratory issues.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sedation success rate after the first dose; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative Recovery Quality Indicators;Induce quality-related indicators;Intraoperative safety indicators;;Anesthesia/Sedation Satisfaction Score.; | — |
Countries
China
Contacts
Public ContactDai Shiyun
Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine
Outcome results
None listed